Literature DB >> 17025270

Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1).

Danxin Wang1, Wolfgang Sadée.   

Abstract

Cis-acting genetic variations can affect the amount and structure of mRNA/protein. Genomic surveys indicate that polymorphisms affecting transcription and mRNA processing, including splicing and turnover, may account for the main share of genetic factors in human phenotypic variability; however, most of these polymorphisms remain yet to be discovered. We use allelic expression imbalance (AEI) as a quantitative phenotype in the search for functional cis-acting polymorphisms in many genes, including ABCB1 (multidrug resistance 1 gene, MDR1, Pgp). Previous studies have shown that ABCB1 activity correlates with a synonymous polymorphism, C3435T; however, the functional polymorphism and molecular mechanism underlying this clinical association remained unknown. Analysis of allele-specific expression in liver autopsy samples and in vitro expression experiments showed that C3435T represents a main functional polymorphism, accounting for 1.5- to 2-fold changes in mRNA levels. The mechanism appears to involve increased mRNA turnover, probably as a result of different folding structures calculated for mRNA with the Mfold program. Other examples of the successful application of AEI analysis for studying functional polymorphism include 5-HTT (serotonin transporter, SLC6A4) and OPRM1 (mu opioid receptor). AEI is therefore a powerful approach for detecting cis-acting polymorphisms affecting gene expression and mRNA processing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17025270      PMCID: PMC2761059          DOI: 10.1208/aapsj080361

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  16 in total

1.  How insects lose their limbs.

Authors:  Mike Levine
Journal:  Nature       Date:  2002-02-21       Impact factor: 49.962

2.  Cis-acting variation in the expression of a high proportion of genes in human brain.

Authors:  Nicholas J Bray; Paul R Buckland; Michael J Owen; Michael C O'Donovan
Journal:  Hum Genet       Date:  2003-05-01       Impact factor: 4.132

Review 3.  Heterochromatin and epigenetic control of gene expression.

Authors:  Shiv I S Grewal; Danesh Moazed
Journal:  Science       Date:  2003-08-08       Impact factor: 47.728

Review 4.  Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.

Authors:  Andrew D Johnson; Danxin Wang; Wolfgang Sadee
Journal:  Pharmacol Ther       Date:  2004-12-15       Impact factor: 12.310

5.  Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues.

Authors:  Danxin Wang; Audrey C Papp; Philip F Binkley; Julie A Johnson; Wolfgang Sadée
Journal:  Pharmacogenet Genomics       Date:  2006-10       Impact factor: 2.089

6.  Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.

Authors:  Andrea Beyer; Thomas Koch; Helmut Schröder; Stefan Schulz; Volker Höllt
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

7.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.

Authors:  Jubao Duan; Mark S Wainwright; Josep M Comeron; Naruya Saitou; Alan R Sanders; Joel Gelernter; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

Review 9.  Genetic polymorphisms of the human MDR1 drug transporter.

Authors:  Matthias Schwab; Michel Eichelbaum; Martin F Fromm
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

Review 10.  Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1).

Authors:  Christiane Pauli-Magnus; Deanna L Kroetz
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.580

View more
  37 in total

Review 1.  Computational approaches to study the effects of small genomic variations.

Authors:  Kamil Khafizov; Maxim V Ivanov; Olga V Glazova; Sergei P Kovalenko
Journal:  J Mol Model       Date:  2015-09-08       Impact factor: 1.810

Review 2.  Genetic factors associated with the development of inflammatory bowel disease.

Authors:  Jesus-K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

3.  Novel mutations in beta-myosin heavy chain, actin and troponin-I genes associated with dilated cardiomyopathy in Indian population.

Authors:  Ushasree Boda; Shivani Vadapalli; Narsimhan Calambur; Pratibha Nallari
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 4.  Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: current and developing technologies.

Authors:  Brian N Chorley; Xuting Wang; Michelle R Campbell; Gary S Pittman; Maher A Noureddine; Douglas A Bell
Journal:  Mutat Res       Date:  2008-05-04       Impact factor: 2.433

5.  The role of Multidrug Resistance-1 (MDR1) variants in response to atorvastatin among Jordanians.

Authors:  Karem H Alzoubi; Omar F Khabour; Sayer I Al-Azzam; Fadia Mayyas; Nizar M Mhaidat
Journal:  Cytotechnology       Date:  2014-01-11       Impact factor: 2.058

6.  Hypothalamic expression of porcine leptin receptor (LEPR), neuropeptide Y (NPY), and cocaine- and amphetamine-regulated transcript (CART) genes is influenced by LEPR genotype.

Authors:  Cristina Ovilo; Almudena Fernández; Ana I Fernández; Josep M Folch; Luis Varona; Rita Benítez; Yolanda Nuñez; Carmen Rodríguez; Luis Silió
Journal:  Mamm Genome       Date:  2010-12-03       Impact factor: 2.957

7.  Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism.

Authors:  L Oleson; L L von Moltke; D J Greenblatt; M H Court
Journal:  Xenobiotica       Date:  2010-02       Impact factor: 1.908

8.  Identification of a variant form of tyrosine phosphatase LYP.

Authors:  Shaofeng Wang; Hongbo Dong; Jiayu Han; Wanting T Ho; Xueqi Fu; Zhizhuang J Zhao
Journal:  BMC Mol Biol       Date:  2010-11-02       Impact factor: 2.946

9.  Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat.

Authors:  Sarah E Lacher; Julia N Gremaud; Kasse Skagen; Emily Steed; Rachel Dalton; Kent D Sugden; Fernando Cardozo-Pelaez; Catherine M T Sherwin; Erica L Woodahl
Journal:  J Pharmacol Exp Ther       Date:  2013-12-02       Impact factor: 4.030

Review 10.  Interindividual variability of methadone response: impact of genetic polymorphism.

Authors:  Yongfang Li; Jean-Pierre Kantelip; Pauline Gerritsen-van Schieveen; Siamak Davani
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.